5 7 0 http://purl.obolibrary.org/obo/DIDEO_00000056 evidence information from clinical study 'evidence information from clinical study' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'clinical study design')) and (http://purl.obolibrary.org/obo/OBI_0000293 some 'drug product'))) http://purl.obolibrary.org/obo/DIDEO_00000061 evidence information from case report 'evidence information from case report' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and (http://purl.obolibrary.org/obo/RO_0002404 some ('adverse drug event' and (http://purl.obolibrary.org/obo/BFO_0000062 some ('drug administration' and ('has participant' some 'drug product'))))))) http://purl.obolibrary.org/obo/DIDEO_00000062 evidence information from observational study 'evidence information from observational study' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some (('assay' and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'observation design'))) and (http://purl.obolibrary.org/obo/OBI_0000293 some http://purl.obolibrary.org/obo/BFO_0000040))) http://purl.obolibrary.org/obo/DIDEO_00000071 evidence information from CYP450 recombinant metabolic enzyme inhibition experiment 'evidence information from CYP450 recombinant metabolic enzyme inhibition experiment' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and ('has part' some ('negative regulation of biological process' and ('has participant' some 'cytochrome P450'))) and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'in vitro design')) and (http://purl.obolibrary.org/obo/OBI_0000293 some 'cell line') and (http://purl.obolibrary.org/obo/OBI_0000293 some ('chemical substance' and ('part of' some ('metabolite' or 'drug product')) and ('participates in' some 'metabolic process'))))) 'evidence information from CYP450 recombinant metabolic enzyme inhibition experiment' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'clinical study design')) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'object drug role'))) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'precipitant drug role'))))) http://purl.obolibrary.org/obo/DIDEO_00000072 evidence information from CYP450 human microsome metabolic enzyme inhibition experiment 'evidence information from CYP450 human microsome metabolic enzyme inhibition experiment' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and ('has part' some ('negative regulation of biological process' and ('has participant' some 'cytochrome P450'))) and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'in vitro design')) and (http://purl.obolibrary.org/obo/OBI_0000293 some 'tissue specimen') and (http://purl.obolibrary.org/obo/OBI_0000293 some ('chemical substance' and ('part of' some ('metabolite' or 'drug product')) and ('participates in' some 'metabolic process'))))) 'evidence information from CYP450 human microsome metabolic enzyme inhibition experiment' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and (not ('has part' some 'group randomization')) and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'clinical study design')) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'object drug role'))) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'precipitant drug role'))))) http://purl.obolibrary.org/obo/DIDEO_00000074 evidence information from randomized drug-drug interaction clinical trial 'evidence information from randomized drug-drug interaction clinical trial' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and ('has part' some 'group randomization') and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'clinical study design')) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'object drug role'))) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'precipitant drug role'))))) 'evidence information from randomized drug-drug interaction clinical trial' SubClassOf 'evidence information content entity' http://purl.obolibrary.org/obo/DIDEO_00000075 evidence information from pharmacokinetic trial 'evidence information from pharmacokinetic trial' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and ('has part' some 'pharmacokinetic process') and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'clinical study design')) and (http://purl.obolibrary.org/obo/OBI_0000293 some 'drug product'))) 'evidence information from pharmacokinetic trial' SubClassOf 'evidence information content entity' http://purl.obolibrary.org/obo/DIDEO_00000076 evidence information from genotyped pharmacokinetic trial 'evidence information from genotyped pharmacokinetic trial' SubClassOf 'evidence information content entity' 'evidence information from genotyped pharmacokinetic trial' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and ('has part' some 'pharmacokinetic process') and ('has part' some 'genotyping') and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'clinical study design')) and (http://purl.obolibrary.org/obo/OBI_0000293 some 'drug product'))) http://purl.obolibrary.org/obo/DIDEO_00000077 evidence information from observation-based report 'evidence information from observation-based report' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and ('causally downstream of' some http://purl.obolibrary.org/obo/BFO_0000003))) 'evidence information from observation-based report' SubClassOf 'evidence information content entity' http://purl.obolibrary.org/obo/DIDEO_00000073 evidence information from parallel groups drug-drug interaction clinical trial' 'evidence information from parallel groups drug-drug interaction clinical trial'' SubClassOf 'evidence information content entity' 'evidence information from parallel groups drug-drug interaction clinical trial'' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some ('assay' and (not ('has part' some 'group randomization')) and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some ('clinical study design' and ('has part' some 'parallel group design')))) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'object drug role'))) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'precipitant drug role'))))) http://purl.obolibrary.org/obo/DIDEO_00000078 evidence information from observational pharmacokinetic study 'evidence information from observational pharmacokinetic study' SubClassOf 'evidence information content entity' 'evidence information from observational pharmacokinetic study' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some (('assay' and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'observation design'))) and ('has part' some 'pharmacokinetic process') and (http://purl.obolibrary.org/obo/OBI_0000293 some 'drug product'))) http://purl.obolibrary.org/obo/DIDEO_00000079 evidence information from observational drug-drug interaction study 'evidence information from observational drug-drug interaction study' EquivalentTo 'evidence information content entity' and (http://purl.obolibrary.org/obo/IAO_0000136 some (('assay' and (http://purl.obolibrary.org/obo/BFO_0000055 some (http://purl.obolibrary.org/obo/RO_0000059 some 'observation design'))) and ('has part' some 'pharmacokinetic process') and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'object drug role'))) and (http://purl.obolibrary.org/obo/OBI_0000293 some ('drug product' and (http://purl.obolibrary.org/obo/RO_0000053 some 'precipitant drug role'))))) 'evidence information from observational drug-drug interaction study' SubClassOf 'evidence information content entity'